|
C6ORF115 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.73769999792739E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.90760000415591E-08 |
| Normal-vs-Stage2 |
7.399900E-03 |
| Normal-vs-Stage3 |
1.577970E-02 |
| Normal-vs-Stage4 |
2.550400E-01 |
| Stage1-vs-Stage2 |
6.297800E-01 |
| Stage1-vs-Stage3 |
3.477400E-01 |
| Stage1-vs-Stage4 |
2.119800E-01 |
| Stage2-vs-Stage3 |
7.740800E-01 |
| Stage2-vs-Stage4 |
4.166600E-01 |
| Stage3-vs-Stage4 |
5.892600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65430000031996E-07 |
| Normal-vs-AfricanAmerican |
4.91479999997768E-06 |
| Normal-vs-Asian |
1.021220E-01 |
| Caucasian-vs-AfricanAmerican |
5.330000E-01 |
| Caucasian-vs-Asian |
3.334000E-01 |
| AfricanAmerican-vs-Asian |
5.007600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.46400000297942E-08 |
| Normal-vs-Female |
3.642200E-04 |
| Male-vs-Female |
7.570200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.350100E-04 |
| Normal-vs-Extreme_Weight |
9.68329999961881E-07 |
| Normal-vs-Obese |
2.184000E-04 |
| Normal-vs-Extreme_Obese |
1.519650E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.372800E-01 |
| Normal_Weight-vs-Obese |
4.689800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.170600E-01 |
| Extreme_Weight-vs-Obese |
6.937800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.949000E-01 |
| Obese-vs-Extreme_Obese |
8.456600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.046300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.08780000007691E-07 |
| Normal-vs-Age(61-80Yrs) |
9.42190000019494E-07 |
| Normal-vs-Age(81-100Yrs) |
1.020230E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.310600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.682200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.880000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.472600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.798800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.579200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.06889999576632E-08 |
| Normal-VS-Type2 PRCC |
3.08059999953869E-07 |
| Normal-VS-KIRP CIMP |
5.837400E-04 |
| Normal-VS-Unclassified PRCC |
1.964720E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.999650E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.58120000426365E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
6.744100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.68179914439293E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
1.336150E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.392199999958E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.555600E-04 |
| Normal-vs-N1 |
1.395930E-02 |
| Normal-vs-N2 |
8.797800E-01 |
| N0-vs-N1 |
9.529000E-01 |
| N0-vs-N2 |
2.515000E-01 |
| N1-vs-N2 |
3.278200E-01 |
|
|
